Franklin Templeton's Alternatives Push Is Turning Into Organic Growth, UBS Says

MT Newswires Live
17 hours ago

Franklin Templeton's (BEN) years of investment in alternatives, separately managed accounts and active exchange-traded funds are starting to deliver organic growth and wider margins, which should support more durable earnings, UBS said in a note emailed Wednesday.

The bank said the asset manager is on track for positive organic growth in fiscal 2026 for the first time in over a decade, with private markets strength offsetting legacy active outflows.

UBS also expects operating margins to keep expanding, supported by expense discipline, operating leverage and a growing contribution from higher-margin private assets.

The bank assumed coverage on the stock with a buy rating and $40 per share price target.

Price: 32.50, Change: +0.05, Percent Change: +0.17

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10